Sister Study

Last updated
The Sister Study
Sister two.jpg
Funding agency NIEHS, United States Department of Health and Human Services
Participants50,000 Women ages 35 to 74 whose sisters had breast cancer
Duration2003 –
Website sisterstudy.niehs.nih.gov

The Sister Study is a nationwide effort, conducted by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health of the U.S. Department of Health and Human Services to learn how the environment and genes may affect the chances of getting breast cancer. [1] Over 10 years, the study followed 50,000 sisters of women who have had breast cancer in hopes of finding the environmental and genetic causes of the disease. As of 2024, the study is the largest and longest of its kind to examine breast cancer risk factors. [2]

Contents

Sister Study participants were women ages 35 to 74. [3] Women were eligible to participate if their sister (living or deceased), related to them by blood, had breast cancer; they had never had breast cancer themselves, and they lived in the United States or Puerto Rico. The Sister Study was available in English and Spanish. [3] Recruitment for the study began in 2004 and closed in 2009. [3]

The principal investigators for the study are Dale Sandler and Clarice Weinberg and the study was overseen by Marian Johnson-Thompson. [3] [4] Organizations in partnership with the Sister Study included the American Cancer Society, the Intercultural Cancer Council, the National Center on Minority Health and Health Disparities of the National Institutes of Health, Sisters Network Inc., Y-ME National Breast Cancer Organization, Susan G. Komen for the Cure, and Breast Cancer Network of Strength. [5]

Beginnings and objectives

Since its beginning in 2003, the Sister Study has incorporated more than 55,000 women whose sisters have had breast cancer. [6] Women of all backgrounds and ethnicities have been included in the study for a broader representation of women's health. [2] The study includes sisters because they are often more likely to continue participating because a family member experienced the disease. [7] Using sisters as subjects also provides a higher chance of identifying the potential risk factors because of their shared environment, genetics, and experiences. [8]

In the 1980s and 1990s, advocacy groups began raising concerns about the rising breast cancer rates in the U.S. [6] In 1990, an estimated 500,000 women would die in the U.S. from cervical and breast cancers. [9] Many advocacy groups called for more studies on breast cancer to improve women’s health, as existing research primarily focused on hormones, lifestyle, and reproduction. [7] In response to these concerns, the NIEHS researchers proposed the idea of the Sister Study. The common features shared between sisters, including genes and early-life environments, provided insights into how genes and environments affect the risk of developing breast cancer associated with these factors. [10] It was supported by study data that these features make women whose sisters had breast cancer twice as likely to develop the disease themselves. [11] The study began by considering the endocrine-disrupting chemical exposures that were of concern to breast cancer advocates, but the researchers wanted to address a range of individual and community-level stressors, such as air pollution and lifestyle factors. [10] The researchers also aimed to include broader public health concerns such as psychological stress, sleep patterns, diet, and socioeconomic and neighborhood factors. [10] Additionally, the researchers aimed to address the research gaps about the impact of exposures in early life—in utero environments to childhood and adolescent experience—on the individual's long-term health. [10]

Graph showing breast cancer incidence by age group among UK women. Data from Cancer Research UK. [1] Breast cancer incidence by age.tif
Graph showing breast cancer incidence by age group among UK women. Data from Cancer Research UK. [1]

The first participant was enrolled 20 years ago, in the fall of 2003, and by the spring of 2009, the study surpassed its goal of 50,000 enrollees with a final count of 50,884 women. [6] The study was originally designed to have a 10-year follow-up, but the participants continued their commitment to the study by providing consistent response rates, which inspired the researchers to keep expanding the scope to include new topics of interest, including other cancers, cardiovascular diseases, respiratory outcomes, and gynecological conditions. [6]

October 2024 marks the 20th anniversary of the Sister Study, making it the nation’s largest and longest ongoing study of women with a close family history of breast cancer. [7] Despite current research, breast cancer remained the leading type of incident cancer in 2021. [11] In 2024, breast cancer remains the second most common cancer for women in the U.S., with about 1 in 8 women being diagnosed in their lifetime. [12] By continuing to study these sisters, the researchers hope to have an increased ability to detect disease risks related to both the environment and genes. [10]

Recruitment and study rationale

Recruitment for the study began in 2003, but nationwide enrollment began in October 2004 through March 2009. [13] To be eligible, women must have been 35 to 74 years of age, living in the United States or Puerto Rico, and had a sister who was diagnosed with breast cancer but was not diagnosed themselves. [13] For each targeted demographic, the study involved recruiters representing those groups. [14] The Sister Study aimed to recruit a diverse group of volunteers to ensure the results would benefit a majority of women—researchers encouraged African American, Latina, Native American, and Asian women, as well as women 60 and older, to join the study. [2] The study materials were made available in Spanish in 2005 to appeal to non-English speaking participants.

The study population included 8,311 women (16%) who self-identified as Hispanic/Latina or non-White, 8,874 women aged 65 years and older (17%), and 7,805 women with a high school education or less (15%). [2] A small percentage of participants (n=3,066) completed some but not all of the study requirements. [2] Even though they did not complete all parts, this group is followed through record linkage—vital statistics and cancer registries—to assess the outcomes for participants who did and did not fully enroll. Of the women who did not complete all of the study requirements, a more significant percentage were minority women (36%). They also had fewer years of schooling (18%) than the participants who continued the study. [2] In the later stages of recruitment, these demographics became the focus so as not to neglect these groups in the results.

Each fully enrolled participant must have submitted baseline data—data that is collected to determine the starting point before study intervention—before beginning the study. [2] [13] [15] The researchers used questionnaires to gather medical histories, environmental exposures, and lifestyle data. DNA was extracted from the blood or saliva samples to determine whether certain breast cancers were hormonally related. The Sister Study Early Study Concept (ESC) Form can be found on the Sister Study website.

Follow-up and participant tracking

After 20 years, the Sister Study is still being conducted to understand the relationship between the environment and genetics impact health outcomes. [6] Researchers follow the cohort to identify breast cancer diagnoses and other health conditions. Through the Sister Study website, participants can report a breast cancer diagnosis or additional health conditions, fill out the follow-up questionnaires, or contact the study help desk by phone, mail, or email. The women complete annual follow-up questionnaires, update their contact information, and report any changes to their health. All materials are available in English and Spanish to ensure all participants can complete the materials. [6]

Findings and contributions

The study has supported many of the factors that can contribute to a woman developing breast cancer, including air pollution, trauma, psychosocial stress, diet, permanent hair dye and chemical hair straighteners, some ingredients in personal care products, and obesity. During the study, the researchers also found a correlation between exposure-related changes to DNA and advanced biological aging as a factor for developing breast cancer. [6] As of August 2023, epidemiologists and public health researchers from the NIEHS have collaborated with other research organizations to publish nearly 300 research papers. [6] A majority of papers have been published in the Environmental Health Perspectives journal as their research interest overlaps with the Sister Study’s. Many of the reports have supported links between breast cancer and genetics and environmental factors.

Related Research Articles

<span class="mw-page-title-main">Breast cancer</span> Cancer that originates in mammary glands

Breast cancer is a cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.

<span class="mw-page-title-main">Penetrance</span> Proportion of individuals that express the trait associated with an allele

Penetrance in genetics is the proportion of individuals carrying a particular variant of a gene (genotype) that also expresses an associated trait (phenotype). In medical genetics, the penetrance of a disease-causing mutation is the proportion of individuals with the mutation that exhibit clinical symptoms among all individuals with such mutation. For example: If a mutation in the gene responsible for a particular autosomal dominant disorder has 95% penetrance, then 95% of those with the mutation will go on to develop the disease, showing its phenotype, whereas 5% will not. 

<span class="mw-page-title-main">Environmental health</span> Public health branch focused on environmental impacts on human health

Environmental health is the branch of public health concerned with all aspects of the natural and built environment affecting human health. To effectively control factors that may affect health, the requirements that must be met to create a healthy environment must be determined. The major sub-disciplines of environmental health are environmental science, toxicology, environmental epidemiology, and environmental and occupational medicine.

A cancer cluster is a disease cluster in which a high number of cancer cases occurs in a group of people in a particular geographic area over a limited period of time.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is one of the National Institutes of Health (NIH) in the United States Department of Health and Human Services. It supports and conducts research aimed at improving the health of children, adults, families, and communities, including:

The National Institute of Environmental Health Sciences (NIEHS) conducts research into the effects of the environment on human disease, as one of the 27 institutes and centers of the National Institutes of Health (NIH). It is located in the Research Triangle Park in North Carolina, and is the only primary division of the NIH located outside of the Washington metropolitan area.

<span class="mw-page-title-main">Women's Health Initiative</span> Long-term U.S. health study

The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS). In particular, randomized controlled trials were designed and funded that addressed cardiovascular disease, cancer, and osteoporosis.

<span class="mw-page-title-main">Diseases of affluence</span> Health conditions thought to be a result of increasing wealth in society

Diseases of affluence, previously called diseases of rich people, is a term sometimes given to selected diseases and other health conditions which are commonly thought to be a result of increasing wealth in a society. Also referred to as the "Western disease" paradigm, these diseases are in contrast to "diseases of poverty", which largely result from and contribute to human impoverishment. These diseases of affluence have vastly increased in prevalence since the end of World War II.

An environmental factor, ecological factor or eco factor is any factor, abiotic or biotic, that influences living organisms. Abiotic factors include ambient temperature, amount of sunlight, air, soil, water and pH of the water soil in which an organism lives. Biotic factors would include the availability of food organisms and the presence of biological specificity, competitors, predators, and parasites.

The Environmental Determinants of Diabetes in the Young is a longitudinal study examining the environmental causes of Type 1 diabetes (T1D), formerly known as juvenile diabetes. The study follows children at high genetic risk for T1D from birth to 15 years of age.

<span class="mw-page-title-main">Risk factors for breast cancer</span> Overview article

Risk factors for breast cancer may be divided into preventable and non-preventable. Their study belongs in the field of epidemiology. Breast cancer, like other forms of cancer, can result from multiple environmental and hereditary risk factors. The term environmental, as used by cancer researchers, means any risk factor that is not genetically inherited.

CARTaGENE is a population-based cohort based on an ongoing and long-term health study of 40,000 men and women in Québec. It is a regional cohort member of the Canadian Partnership for Tomorrow's Health (CanPath). The project's core mandate is to identify the genetic and environmental causes of common chronic diseases affecting the Québecois population, and to develop personalized medicine and public policy initiatives targeting high-risk groups for the public.

<span class="mw-page-title-main">GuLF Study</span>

The GuLF Study, or Gulf Long-term Follow-up Study, is a five-year research project examining the human-health consequences of the Deepwater Horizon oil spill in April 2010. The spill followed an explosion on a drilling rig leased by BP, the British oil company, and led to the release of over four million barrels of oil into the Gulf of Mexico, 48 miles off the coast of Louisiana in the United States.

<span class="mw-page-title-main">Linda Birnbaum</span> American toxicologist

Linda Silber Birnbaum is an American toxicologist, microbiologist and the former director of the National Institute for Environmental Health Sciences, as well as the National Toxicology Program, positions she held from January 18, 2009 until October 3, 2019. She also serves as an adjunct professor at the University of North Carolina at Chapel Hill School of Public Health and as a member of the editorial board of Environment International.

<span class="mw-page-title-main">Darlene Dixon</span> American veterinary scientist and toxicologic pathologist

Darlene Dixon is an American veterinary scientist and toxicologic pathologist researching the pathogenesis/carcinogenesis of tumors affecting the reproductive tract of rodents and humans and assessing the role of environmental and endogenous hormonal factors in the growth of these tumors. She is a senior investigator at the National Institute of Environmental Health Sciences.

<span class="mw-page-title-main">Marian Johnson-Thompson</span> American virologist (born 1946)

Marian Cecelia Johnson-Thompson is an American virologist who was a professor at the University of the District of Columbia. She was elected Fellow of the American Association for the Advancement of Science.

The Strong Heart Study is an ongoing cohort study of cardiovascular disease (CVD) and its risk factors among American Indian men and women. The original cohort began in 1984 with 4,549 participants ages 35–74 from 13 tribal nations and communities in Arizona, Oklahoma, North Dakota, and South Dakota. The need for specific ethnic and cultural understanding and sensitivities was recognized from the onset, so the study has a community-based participatory research (CBPR) model. Community members were involved in all stages of conception, design, and implementation of the research. Now in its seventh phase, the extensive research has led to many important findings about heart disease and unique risk factors in native populations. It is a project funded by the National Heart, Lung, and Blood Institute (NHLBI). The study maintains field centers in Oklahoma, North and South Dakota, and Arizona and a coordinating center at the University of Oklahoma Health Sciences Center.

<span class="mw-page-title-main">Stephanie J. London</span> American physician

Stephanie J. London is an American epidemiologist and physician-scientist specializing in environmental health, respiratory diseases, and genetic susceptibility. She is the deputy chief of the epidemiology branch at the National Institute of Environmental Health Sciences.

<span class="mw-page-title-main">Gwen W. Collman</span> American environmental epidemiologist

Gwen W. Collman is an American environmental epidemiologist. Collman is acting deputy director of the National Institute of Environmental Health Sciences and works as director of the division of extramural research and training.

<span class="mw-page-title-main">Mia M. Gaudet</span> American molecular epidemiologist

Mia M. Gaudet is an American molecular epidemiologist pectized in cancer prevention research and managing cohort studies. She is a senior scientist in the division of cancer epidemiology and genetics at the National Cancer Institute.

References

  1. ↑ "What is the Sister Study?". The Sister Study. Retrieved 2021-09-23.
  2. 1 2 3 4 5 6 7 "50,000 Sisters Of Women With Breast Cancer Needed To Help Find Causes Of The Disease". ScienceDaily. Retrieved 2024-10-09.
  3. 1 2 3 4 "Sister Study". National Institute of Environmental Health Sciences. Retrieved 2021-09-23.
  4. ↑ "Marian Johnson-Thompson". UNC Lineberger. Retrieved 2021-09-23.
  5. ↑ "FAQ". The Sister Study. Retrieved 2021-09-23.
  6. 1 2 3 4 5 6 7 8 "Sister Study Turns 20". National Institute of Environmental Health Sciences. Retrieved 2024-10-09.
  7. 1 2 3 Epidemiologic Contribution to Understanding the Environmental Impact on Women’s Health: The NIEHS Sister Study (nih.gov)
  8. ↑ "The Sister Study: What is the Sister Study". sisterstudy.niehs.nih.gov. Retrieved 2024-10-09.
  9. ↑ "Update: National Breast and Cervical Cancer Early Detection Program, 1992-1993". www.cdc.gov. Retrieved 2024-10-09.
  10. 1 2 3 4 5 Sister Study Collection | EHP Publishing (nih.gov)
  11. 1 2 Giaquinto, Angela N.; Sung, Hyuna; Miller, Kimberly D.; Kramer, Joan L.; Newman, Lisa A.; Minihan, Adair; Jemal, Ahmedin; Siegel, Rebecca L. (November 2022). "Breast Cancer Statistics, 2022". CA: A Cancer Journal for Clinicians. 72 (6): 524–541. doi: 10.3322/caac.21754 . ISSN   0007-9235. PMID   36190501.
  12. ↑ CDC (2024-09-16). "Breast Cancer Statistics". Breast Cancer. Retrieved 2024-10-09.
  13. 1 2 3 The Sister Study (nih.gov)
  14. ↑ "Voices of the Sister Study". NIH MedlinePlus Magazine. Retrieved 2024-10-09.
  15. ↑ "Baseline Study in Monitoring and Evaluation: Definition, Importance, and Steps Involved". EvalCommunity. Retrieved 2024-10-09.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.